<DOC>
	<DOC>NCT01208532</DOC>
	<brief_summary>The aim of this study is to evaluate the reliability and validity of the Korean version of the European Organization for Research and Treatment of Cancer High-dose Chemotherapy module (EORTC HDC-29).</brief_summary>
	<brief_title>Validation Study of the Korean Version of the EORTC QLQ-HDC29</brief_title>
	<detailed_description />
	<criteria>Patients who are aged more than 18 years Patients who are diagnosed with hematologic malignancies and who are planned to receive highdose chemotherapy followed by allogeneic or autologous stem cell transplantation (SCT) Patients who agree with the informed consent Patients who are unable to complete the questionnaire due to the serious physical or psychological morbidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>